$JANX
Janux Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
JANX chart
What traders are saying about $JANX
Latest postsJanux Therapeutics, Inc. news
- Janux Therapeutics, Inc. (JANX) Discusses JANX011 Phase 1 Healthy Volunteer Data and Autoimmune Development Strategy - Slideshow (NASDAQ:JANX) 2026-11-10
Seeking Alpha ·
- Janux Therapeutics Stock In Focus As Loss Narrows And Phase 1 Data Nears
Yahoo Finance ·
- Transcript : Janux Therapeutics, Inc. - Special Call
www.marketscreener.com ·
- Janux Therapeutics (JANX) Reports Promising Phase 1 Trial Results, Stock Dips 25%
GuruFocus ·
- Janux Reports Deep B-Cell Depletion in Initial Phase 1 Trial of JANX011; Shares Fall
Yahoo Finance ·
- Janux Therapeutics Announces Positive Initial Phase 1 Data for...
Quantisnow ·
- Janux Therapeutics Announces Positive Initial Phase 1 Data for JANX011 in Healthy Volunteers, Supporting Planned Development in Patients with Autoimmune Disease
Yahoo Finance ·
- Janux Therapeutics, Inc. (JANX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Janux Therapeutics (JANX) Earnings Beat Puts Its Pricey Valuation Back In Focus
Simply Wall St ·
- Janux Therapeutics, Inc. (JANX) stock price, news, quote and history
Yahoo Finance UK ·
- Janux Therapeutics, Inc. (JANX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Janux Therapeutics (JANX) Earnings Beat Brings Its Pricey Valuation Back Into Focus
Yahoo Finance ·
Janux Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$113.6M | -$69.0M | -$58.3M | -$63.1M |
| Diluted EPS | $-1.83 | $-1.28 | $-1.32 | $-1.52 |
| Total assets (year end) | $1.00B | $1.06B | $380.4M | $364.0M |
| Cash and equivalents (year end) | $52.3M | $430.6M | $19.2M | $51.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Janux Therapeutics, Inc.
- Ticker
- JANX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1817713
Frequently asked questions
What exchange is Janux Therapeutics, Inc. listed on?
Janux Therapeutics, Inc. trades on the Nasdaq under the ticker symbol JANX.
What industry is Janux Therapeutics, Inc. in?
Janux Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Janux Therapeutics, Inc. headquartered?
Janux Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Janux Therapeutics, Inc.'s fiscal year end?
Janux Therapeutics, Inc.'s fiscal year ends on December 31.